These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2466138)

  • 1. Pars plana vitrectomy in chronic myelogenous leukemia with vitreous hemorrhage.
    Hasanreisoğlu B; Or M; Atmaca LS; Haznedar R
    Jpn J Ophthalmol; 1988; 32(3):304-9. PubMed ID: 2466138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vitreous hemorrhages in proliferative diabetic retinopathy treated with pars plana vitrectomy--own material].
    Kanclerz P; Pyrzanowska-Sumita J; Murawska J; Raczyńska D; Gebka A
    Klin Oczna; 2013; 115(4):291-5. PubMed ID: 24908919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH
    Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proliferative retinopathy in chronic myeloid leukemia].
    Hoerauf H; Bopp S; Laqua H
    Klin Monbl Augenheilkd; 1994 Oct; 205(4):226-30. PubMed ID: 7823523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-port pars plana vitrectomy surgery: a prospective interventional case series.
    Colucciello M
    Eye (Lond); 2005 Aug; 19(8):869-72. PubMed ID: 15359245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual loss as initial presentation of chronic myelogenous leukemia.
    Mandić BD; Potocnjak V; Bencić G; Mandić Z; Pentz A; Hajnzić TF
    Coll Antropol; 2005; 29 Suppl 1():141-3. PubMed ID: 16193698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].
    Li X; Jiang Y; Ye C; Li C
    Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):116-8. PubMed ID: 11835788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vitreous hemorrhage and pre-retinal hemorrhage "without obvious point of origin" in diabetic patients. Apropos of 5 cases].
    Basteau F; Mortemousque B; Verin P; Barac'h D
    J Fr Ophtalmol; 1999 May; 22(5):528-35. PubMed ID: 10417911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vitreous hemorrhage: attitudes in therapy, vitrectomy].
    Mathis A; Pagot V; Malecaze F
    Diabete Metab; 1993; 19(5):436-40. PubMed ID: 8056123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of vitreous hemorrhages. Spontaneous hemorrhages].
    Ruellan YM
    Bull Soc Ophtalmol Fr; 1987 Nov; Spec No():41-48, 51-8, 61-8 passim. PubMed ID: 2448052
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vitrectomy in Terson's Syndrome].
    Urbanowicz-Nowakowska J; Wesołek-Czernik A; Nawrocki J; Dziegielewski K
    Klin Oczna; 1996 Feb; 98(2):131-2. PubMed ID: 9026571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitrectomy for non-diabetic vitreous hemorrhage].
    Wang GL; Pang XG
    Zhonghua Yan Ke Za Zhi; 1990 Nov; 26(6):349-51. PubMed ID: 2086155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined extracapsular cataract extraction, posterior chamber intraocular lens implantation, and pars plana vitrectomy.
    Foster RE; Lowder CY; Meisler DM; Zakov ZN; Meyers SM; Ambler JS
    Ophthalmic Surg; 1993 Jul; 24(7):446-52. PubMed ID: 8351090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of a repeat vitrectomy in patients with recurrent hemorrhages into the vitreous body in diabetic retinopathy].
    Glinchuk IaI; Deev LA; Iugaĭ AG; Khalil' A
    Vestn Oftalmol; 1987; 103(3):23-6. PubMed ID: 2442875
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vitrectomy and proliferative diabetic retinopathy. Apropos of 66 eyes].
    Bouchard O; Zech JC; Trepsat C
    J Fr Ophtalmol; 1997; 20(4):263-70. PubMed ID: 9181137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Terson syndrome--a contribution to the timing of operation for pars plana vitrectomy].
    Augsten R; Königsdörffer E
    Klin Monbl Augenheilkd; 2007 Aug; 224(8):674-7. PubMed ID: 17717786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for postoperative hemorrhage after vitrectomy for diabetic retinopathy.
    Soto-Pedre E; Hernaez-Ortega MC; Vazquez JA
    Ophthalmic Epidemiol; 2005 Oct; 12(5):335-41. PubMed ID: 16272053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATYPICAL PROLIFERATIVE RETINOPATHY AS THE PRESENTING FEATURE OF CHRONIC MYELOID LEUKEMIA IN A PATIENT WITH DIABETES MELLITUS.
    Al Falah M; Ballios BG; Yeung SC; Mehraban Far P; Yan P
    Retin Cases Brief Rep; 2023 Jan; 17(1):61-64. PubMed ID: 33252507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal and optic disc neovascularization in leukaemia.
    Anderton L; Amoaku WM; Noble BA
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):752-6. PubMed ID: 7747589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.